Holen Sie sich die Stockscreener-App
12.21
4.36%
0.51
Handel nachbörslich:
12.21
Autonomix Medical Inc Aktie (AMIX) Neueste Nachrichten
Autonomix reports results from first 15 patients’ data on transvascular energy - MSN
Autonomix Medical Shares Rise After Positive Trial for Pancreatic Cancer Pain Treatment - MarketWatch
Autonomix (AMIX) Gains Investor Confidence After Encouraging Trial Results - Stocks Telegraph
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - StreetInsider.com
Autonomix Medical, Inc. Reports New Positive Topline - GlobeNewswire
Autonomix Medical (AMIX) Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - StreetInsider.com
Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses - GlobeNewswire
Autonomix participates in Virtual Investor ‘What This Means’ segment - TipRanks
AMIS Stock Surges After RF Ablation Trial Unveils Positive Results - MSN
Monte Rosa Therapeutics, Evoke Pharma, and Autonomix Medical: The Top 3 Stocks Capturing Retail Attention - Barchart
Autonomix announces preliminary results from trial on ablation technology - TipRanks
Autonomix Shares Soar 85% on Results From Pain-Management Study - MarketWatch
Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher - Benzinga
Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday? - Benzinga
Autonomix (AMIX) Stock Soars On Positive Pain Management Trial Outcomes - Stocks Telegraph
Autonomix jumps after its treatment reduces pain during trial - XM
Autonomix reports breakthrough in pancreatic cancer pain - Investing.com India
Positive Preliminary Results Demonstrate Autonomix’s - GlobeNewswire
Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial - StockTitan
1,518,000 Common Stock of Autonomix Medical, Inc. are subject to a Lock-Up Agreement Ending on 27-OCT-2024. - Marketscreener.com
Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th - GlobeNewswire
Autonomix Medical to conduct a reverse stock split - MSN
Autonomix Medical announces 1-for-20 reverse stock split By Investing.com - Investing.com Canada
Nerve ablation tech developer Autonomix to effect a reverse stock split - Mass Device
Autonomix Announces Reverse Stock Split - citybiz
Autonomix Medical announces 1-for-20 reverse stock split - Investing.com
Autonomix Medical ratifies new auditor, approves reverse stock split - Investing.com India
Autonomix Medical ratifies new auditor, approves reverse stock split By Investing.com - Investing.com South Africa
Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC - GlobeNewswire
This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer - AccessWire
Autonomix Flat on Unveiling Corner Segment - Baystreet.ca
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment - GlobeNewswire
Potential Price Increase for Vor Biopharma Inc (VOR) After Recent Insider Activity - Knox Daily
VOR’s Stock Market Adventure: -65.78% YTD Growth Amidst Volatility - The InvestChronicle
Investing in Vor Biopharma Inc (VOR) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Market Resilience: Vor Biopharma Inc (VOR) Finishes Weak at 0.83, Down -7.78 - The Dwinnex
Stock hits 5% upper circuit after Motilal Oswal Mutual Fund bought 2.12% stake - Trade Brains
Motilal Oswal MF buys 2% in smallcap stock that is up 1,515% in 16 months - Business Standard
Autonomix Medical faces potential Nasdaq delisting - Investing.com
Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum - GlobeNewswire
Market Resilience: Vor Biopharma Inc (VOR) Finishes Weak at 0.93, Down -2.48 - The Dwinnex
Vor Biopharma Inc (VOR) requires closer examination - US Post News
Moove, Rappi edge closer to IPOs - LatinFinance
Ladenburg Thalmann Initiates Coverage of Autonomix Medical (AMIX) with Buy Recommendation - MSN
Autonomix rises after it reports reduction of pain in pancreatic cancer treatment - MSN
Autonomix reports pain relief in pancreatic cancer trial - Investing.com India
Autonomix reports pain relief in pancreatic cancer trial By Investing.com - Investing.com Canada
0.47%
1.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):